FDMT

4D Molecular Therapeutics Inc.

• PUBT·05/15 20:05

  4D Molecular Therapeutics grants 141,100 RSUs to 14 new employees

• Simply Wall St·05/11 14:16

  Analysts Have Made A Financial Statement On 4D Molecular Therapeutics, Inc.'s (NASDAQ:FDMT) First-Quarter Report

• TipRanks·05/11 10:36

  Analyst Reiterates Buy on 4D Molecular Therapeutics as Wet AMD Gene Therapy Advances, Keeps $36 Price Target Unchanged

• TipRanks·05/10 13:36

  Daniel Giraldo Reiterates Buy on 4D Molecular Therapeutics, Citing Strong 4D-150 Progress and Undervalued Upside vs. $29 Price Target

• TipRanks·05/08 19:50

  Analysts Offer Insights on Healthcare Companies: Rockwell Med (RMTI), 4D Molecular Therapeutics (FDMT) and Cognition Therapeutics (CGTX)

• TipRanks·05/08 13:03

  RBC Capital Sticks to Their Buy Rating for 4D Molecular Therapeutics (FDMT)

• TipRanks·05/08 12:02

  4D Molecular price target lowered to $33 from $38 at Goldman Sachs

• TipRanks·05/07 22:48

  4D Molecular files $400M mixed securities shelf

• TipRanks·05/07 22:24

  4D Molecular reports Q1 EPS ($1.01), consensus ($1.00)

• Benzinga·05/07 21:53

  4D Molecular Therapeutics Files Prospectus To Offer And Sell Up To $400M Of Securities In Multiple Offerings

• Reuters·05/07 21:00

  4D MOLECULAR THERAPEUTICS INC - MAY OFFER AND SELL UP TO $400 MLN OF SECURITIES IN MULTIPLE OFFERINGS - SEC FILING

• PUBT·05/07 20:46

  4D Molecular Therapeutics posts corporate presentation highlighting 4D-150 retinal gene therapy program

• PUBT·05/07 20:36

  4D Molecular Therapeutics Q1 net loss widens to $68.8 million

• Benzinga·05/07 20:34

  4D Molecular Therapeutics Q1 EPS $(1.01) Misses $(0.99) Estimate, Sales $3.047M Miss $5.167M Estimate

• Dow Jones·05/07 20:05

  Press Release: 4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones